Compound Detail
CHEMBL1773
CAPECITABINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1773 |
| Name | CAPECITABINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | GAGWJHPBXLXJQN-UORFTKCHSA-N |
| Therapeutic | ✓ Yes |
| Active Moiety | CHEMBL185 |
3
Targets
4
Activities
1
Assay Types
0
PK Parameters
20
Publications
20
Known Names
20
Indications
3
Mechanisms
Molecular Properties
359.4
MW (Da)
0.76
ALogP
8
HBA
3
HBD
122.9
PSA (Ų)
0.64
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1998 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Thymidylate synthase inhibitor | INHIBITOR | Thymidylate synthase | ✓ | ✓ |
| DNA inhibitor | INHIBITOR | DNA | ✓ | ✓ |
| RNA inhibitor | INHIBITOR | RNA | ✓ | ✓ |
Indications
Breast Neoplasms Breast Neoplasms Breast Neoplasms Breast Neoplasms Colonic Neoplasms Colonic Neoplasms Colonic Neoplasms Colorectal Neoplasms Colorectal Neoplasms Colorectal Neoplasms Colorectal Neoplasms Neoplasms Neoplasms Stomach Neoplasms Stomach Neoplasms Stomach Neoplasms Stomach Neoplasms Adenocarcinoma Adenocarcinoma Biliary Tract Neoplasms
ATC Classification
L01BC06
capecitabine
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Drug Warnings
Black Box Warning
General Warning
Activity Summary
IC50 4 meas. best 8.36
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 8.36 | 6.86 | 4.3 | 2 |
| KG-1 CHEMBL612264 | IC50 | 5.05 | 5.05 | 8900.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 4.47 | 4.47 | 34200.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| NON-PROTEIN TARGET | IC50 | = | 4.33 | nM | 8.36 | Cytotoxicity against human RKOp27 cells by MTT assay | 19345581 |
| NON-PROTEIN TARGET | IC50 | = | 4330.0 | nM | 5.36 | Cytotoxicity against human RKOp27 cells after 3 days by MTT assay | 20356655 |
| KG-1 | IC50 | = | 8900.0 | nM | 5.05 | Antiproliferative activity against human KG-1 cells assessed as reduction in cel... | 35300092 |
| HCT-116 | IC50 | = | 34200.0 | nM | 4.47 | Antiproliferative activity against human HCT-116 cells assessed as reduction in ... | 35300092 |
Literature References
Data from ChEMBL 36 via Core Engine